Cystatin C and Mortality Risk in the Elderly
Authors:
- Michael G. ShlipakMSMichael G. Shlipak
- Christina L. Wassel FyrCFChristina L. Wassel Fyr
- Glenn M. ChertowGCGlenn M. Chertow
- Tamara B. HarrisTHTamara B. Harris
- Stephen B. KritchevskySKStephen B. Kritchevsky
- Frances A. TylavskyFTFrances A. Tylavsky
- Suzanne SatterfieldSSSuzanne Satterfield
- Steven R. CummingsSCSteven R. Cummings
- Anne B. NewmanANAnne B. Newman
- Linda F. FriedLFLinda F. Fried
Open Access
- 1 January 2006
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (1) , 254-261
Abstract
Kidney dysfunction is known to decrease life expectancy in the elderly. Cystatin C is a novel biomarker of kidney function that may have prognostic utility in older adults. The association of cystatin C with mortality was evaluated in a biracial cohort of black and white ambulatory elderly and compared with that of serum creatinine concentrations. The Health, Aging and Body Composition study is a cohort of well-functioning elderly that was designed to evaluate longitudinal changes in weight, body composition, and function. A total of 3075 participants who were aged 70 to 79 yr and had no disability were recruited at sites in Memphis, TN, and Pittsburgh, PA, between April 1997 and June 1998 with a follow-up of 6 yr. At entry, the mean cystatin C was 1.05 mg/L and the mean creatinine was 1.06 mg/dl. After 6 yr of follow-up, 557 participants had died. The mortality rates in each ascending cystatin C quintile were 1.7, 2.7, 2.9, 3.1, and 5.4%/yr. After adjustment for demographic risk factors, comorbid health conditions, and inflammatory biomarkers (C-reactive protein, IL-6. and TNF-α), each quintile of cystatin C was significantly associated with increased mortality risk compared with the lowest: Hazard ratios (HR; 95% confidence intervals) quintile 1, −1.0 (referent); quintile 2, −1.74 (1.21 to 2.50); quintile 3, −1.51 (1.05 to 2.18); quintile 4, −1.49 (1.04 to 2.13); and quintile 5, −2.18 (1.53 to 3.10). These associations did not differ by gender or race. Results were consistent for cardiovascular and other-cause mortality, but not cancer mortality. Creatinine quintiles were not associated with mortality after multivariate adjustment (HR: 1.0 [referent], 1.00 [0.72 to 1.39], 0.95 [0.68 to 1.32], 1.11 [0.79 to 1.57], 1.16 [0.86 to 1.58]). Cystatin C is a strong, independent risk factor for mortality in the elderly. Future studies should investigate whether cystatin C has a role in clinical medicine.Keywords
This publication has 19 references indexed in Scilit:
- Plasma Concentrations of Cystatin C in Patients with Coronary Heart Disease and Risk for Secondary Cardiovascular Events: More than Simply a Marker of Glomerular Filtration RateClinical Chemistry, 2005
- Cystatin C: A Marker of Renal Function or Something More?Clinical Chemistry, 2005
- Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurementKidney International, 2004
- Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal InsufficiencyCirculation, 2003
- Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysisAmerican Journal of Kidney Diseases, 2002
- Relationship of Interleukin-6 and Tumor Necrosis Factor- With Muscle Mass and Muscle Strength in Elderly Men and Women: The Health ABC StudyThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2002
- Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetesAmerican Journal of Kidney Diseases, 2001
- Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairmentAmerican Journal of Kidney Diseases, 2000
- Pregnancy and Renal Tubular AcidosisAmerican Journal of Perinatology, 1999
- Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II SystemScandinavian Journal of Clinical and Laboratory Investigation, 1999